AI-generated analysis. Always verify with the original filing.
MDJM LTD received a Nasdaq staff determination letter on March 13, 2026, notifying suspension of its securities effective March 20, 2026, due to a closing bid price of $0.10 or less for 10 consecutive business days, compounded by prior reverse stock splits and a discretionary panel monitor. The company plans to request a hearing before a Nasdaq Hearings Panel, expects OTC trading under UOKA during proceedings, and is pursuing compliance options including a reverse stock split effective March 16, 2026.